# Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/idecabtagene-vicleucel-for-relapsed-and-refractory-multiple-myeloma-post-hoc-18/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yi Lin,Noopur Raje,Jesús G. Berdeja,David S. Siegel,Sundar Jagannath,Deepu Madduri,Michaela Liedtke,Jacalyn Rosenblatt,Marcela V. Maus,Monica Massaro,Fabio Petrocca,Ashish Yeri,Olivia Finney,Andrea Caia,Zhihong Yang,Nathan Martin,Timothy Campbell,Julie Rytlewski,Jaymes Fuller,Kristen Hege,Nikhil C. Munshi,James N. Kochenderfer |
| Citations | 124 |
| DOI | 10.1038/s41591-023-02496-0 |
| Fields | Engineering,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.nature.com/articles/s41591-023-02496-0.pdf |
| OpenAlex ID | https://openalex.org/W4385955291 |
| PMID | 37592106 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Timothy Campbell](https://scholariq.org/researchers/timothy-campbell/)

## Paper journal

- [Nature Medicine](https://scholariq.org/journals/nature-medicine/)

## Paper primary topic

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Paper topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Nanowire Synthesis and Applications](https://scholariq.org/topics/nanowire-synthesis-and-applications/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.